FibroGen Inc (FGEN) — Cash Flow-to-Debt Ratio
FibroGen Inc (FGEN) has a Cash Flow-to-Debt Ratio of -0.02x as of September 2025, meaning its operating cash flow of $-1.85 Million could theoretically repay 0% of its total liabilities ($119.53 Million) in one year. Explore how much of FibroGen Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
FibroGen Inc Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for FibroGen Inc across 13 annual periods. Also explore FibroGen Inc balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for FibroGen Inc (2012–2024)
Year-by-year debt coverage analysis for FibroGen Inc. For market capitalisation and broader financial context, see FibroGen Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.35x | $-138.00 Million | $398.16 Million | ▲ +35.6% |
| 2023 | -0.54x | $-315.02 Million | $585.73 Million | ▼ -125.4% |
| 2022 | -0.24x | $-145.93 Million | $611.57 Million | ▼ -58.1% |
| 2021 | -0.15x | $-82.23 Million | $544.71 Million | ▼ -171.3% |
| 2020 | 0.21x | $81.60 Million | $385.39 Million | ▲ +186.6% |
| 2019 | -0.24x | $-78.70 Million | $321.99 Million | ▼ -13.0% |
| 2018 | -0.22x | $-76.14 Million | $352.13 Million | ▼ -2.8% |
| 2017 | -0.21x | $-66.51 Million | $316.20 Million | ▼ -971.4% |
| 2016 | 0.02x | $7.11 Million | $294.44 Million | ▲ +135.6% |
| 2015 | -0.07x | $-18.57 Million | $273.75 Million | ▼ -173.5% |
| 2014 | 0.09x | $22.41 Million | $242.85 Million | ▼ -32.6% |
| 2013 | 0.14x | $25.92 Million | $189.35 Million | ▲ +450.2% |
| 2012 | -0.04x | $-5.61 Million | $143.40 Million | — |